Do reimbursement recommendation processes used by government drug plans in Canada adhere to good governance principles?
Nigel SB Rawson,1–3 John Adams4 1Eastlake Research Group, Oakville, ON, 2Canadian Health Policy Institute, Toronto, ON, 3Fraser Institute, Vancouver, BC, 4Canadian PKU and Allied Disorders Inc., Toronto, ON, Canada Abstract: In democratic societies, good governance is the key to assuring t...
Main Authors: | Rawson NS, Adams J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-11-01
|
Series: | ClinicoEconomics and Outcomes Research |
Subjects: | |
Online Access: | https://www.dovepress.com/do-reimbursement-recommendation-processes-used-by-government-drug-plan-peer-reviewed-article-CEOR |
Similar Items
-
New reimbursement criteria for lipid-lowering drugs
by: Mario Eandi
Published: (2011-06-01) -
Leading Causes of Mortality and Prescription Drug Coverage in Canada and New Zealand
by: Nigel S. B. Rawson, et al.
Published: (2020-10-01) -
What is the role of antineoplastic drug safety in reimbursement decision making?
by: A. S. Kolbin, et al.
Published: (2018-11-01) -
The AIFA time-to-reimbursement: a comparison between the last two committees from 2015 to 2020
by: Paola Raimondo, et al.
Published: (2020-12-01) -
Access to innovative drugs and the National Reimbursement Drug List in China: Changing dynamics and future trends in pricing and reimbursement
by: Bérengère Macabeo, et al.
Published: (2023-12-01)